PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
While not every child responds the same way to supplementation, the research shows that a trial of methyl B12 may be worth consideration.
Cons of Adapt Peptides Research Use Only Adapt Peptides supplies compounds strictly for laboratory research
it contains 1,000mg of urolithin A, which is double the amount Timeline and Codeage offer in their supplements
+ L-Carnitine A naturally occurring amino acid which plays a vital role in the metabolism of fats
Tirzepatide has no established direct mechanism causing vitamin B12 deficiency, unlike metformin